<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cidofovir is an acyclic <z:chebi fb="0" ids="33838">nucleoside</z:chebi> <z:chebi fb="0" ids="16215,26066">phosphonate</z:chebi> with broad-spectrum activity against DNA viruses, including human <z:mpath ids='MPATH_445'>papilloma</z:mpath> virus (HPV) </plain></SENT>
<SENT sid="1" pm="."><plain>However, data on the efficacy of cidofovir in an immunosuppressive setting remain contradictory </plain></SENT>
<SENT sid="2" pm="."><plain>We report for the first time on the promotion of the healing of recalcitrant <z:hpo ids='HP_0200043'>warts</z:hpo> in a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> with intravenous cidofovir treatment </plain></SENT>
</text></document>